NEW YORK, June 5 /PRNewswire/ -- Cline Davis & Mann (CDM), a leading healthcare communication services company, announced the launch of its newest division, Platform Advisors(TM). Platform Advisors, based in New York, provides fully integrated strategic and scientific consulting services for pharmaceutical, biotechnology, and medical device companies.
Unlike traditional consulting firms, Platform Advisors combines the expertise of seasoned healthcare professionals and commercial strategists. The integrated approach provides a single source for strategic and scientific needs at every stage of a product's lifecycle. Platform Advisors has more than 40 medical professionals partnered with seasoned strategists who focus only on commercialization of healthcare products.
Platform Advisors was created in response to a growing customer need for early commercialization strategies. Platform Advisors, led by Lori Klein, Managing Partner, provides services that include portfolio strategy, licensing, valuations, forecasting, early commercialization, and clinical strategy. "With our integrated approach, we offer expertise in both 'The science of business and the business of science' -- at every stage of a product's lifecycle."
"We are really pleased to offer these services for our clients. Now we can partner with companies from discovery to launch and beyond. Our clients have responded enthusiastically to our offering," stated Ed Wise, CEO and Chairman of CDM.
Cline Davis & Mann (http://www.clinedavis.com) is a leading global healthcare communications company. Cline Davis & Mann provides a full range of services, including advertising, managed market strategy, digital and relationship marketing, and consulting. Cline Davis & Mann was named Agency of the Year in 2008 by Med Ad News.
|SOURCE Cline Davis & Mann|
Copyright©2008 PR Newswire.
All rights reserved